209 related articles for article (PubMed ID: 12414948)
1. Replication advantage and host factor-independent phenotypes attributable to a common naturally occurring capsid mutation (I97L) in human hepatitis B virus.
Suk FM; Lin MH; Newman M; Pan S; Chen SH; Liu JD; Shih C
J Virol; 2002 Dec; 76(23):12069-77. PubMed ID: 12414948
[TBL] [Abstract][Full Text] [Related]
2. Persistence of Hepatitis B Virus DNA and the Tempos between Virion Secretion and Genome Maturation in a Mouse Model.
Wu SY; Chang YS; Chu TH; Shih C
J Virol; 2019 Nov; 93(22):. PubMed ID: 31462567
[TBL] [Abstract][Full Text] [Related]
3. Subtype-independent immature secretion and subtype-dependent replication deficiency of a highly frequent, naturally occurring mutation of human hepatitis B virus core antigen.
Yuan TT; Tai PC; Shih C
J Virol; 1999 Dec; 73(12):10122-8. PubMed ID: 10559327
[TBL] [Abstract][Full Text] [Related]
4. Amino Acid Polymorphism in Hepatitis B Virus Associated With Functional Cure.
Honda T; Yamada N; Murayama A; Shiina M; Aly HH; Kato A; Ito T; Ishizu Y; Kuzuya T; Ishigami M; Murakami Y; Tanaka T; Moriishi K; Nishitsuji H; Shimotohno K; Ishikawa T; Fujishiro M; Muramatsu M; Wakita T; Kato T
Cell Mol Gastroenterol Hepatol; 2021; 12(5):1583-1598. PubMed ID: 34352407
[TBL] [Abstract][Full Text] [Related]
5. PGC1α Transcriptional Adaptor Function Governs Hepatitis B Virus Replication by Controlling HBcAg/p21 Protein-Mediated Capsid Formation.
Shalaby RE; Iram S; Çakal B; Oropeza CE; McLachlan A
J Virol; 2017 Oct; 91(20):. PubMed ID: 28768874
[TBL] [Abstract][Full Text] [Related]
6. Carboxy-terminal truncations of the HBV core protein affect capsid formation and the apparent size of encapsidated HBV RNA.
Beames B; Lanford RE
Virology; 1993 Jun; 194(2):597-607. PubMed ID: 7684872
[TBL] [Abstract][Full Text] [Related]
7. Molecular characteristics and functional analysis of full-length hepatitis B virus quasispecies from a patient with chronic hepatitis B virus infection.
Cui XJ; Cho YK; Song HJ; Choi EK; Kim HU; Song BC
Virus Res; 2010 Jun; 150(1-2):43-8. PubMed ID: 20184927
[TBL] [Abstract][Full Text] [Related]
8. Role of core protein mutations in the development of occult HBV infection.
Chen J; Liu B; Tang X; Zheng X; Lu J; Zhang L; Wang W; Candotti D; Fu Y; Allain JP; Li C; Li L; Li T
J Hepatol; 2021 Jun; 74(6):1303-1314. PubMed ID: 33453326
[TBL] [Abstract][Full Text] [Related]
9. Stability and morphology comparisons of self-assembled virus-like particles from wild-type and mutant human hepatitis B virus capsid proteins.
Newman M; Suk FM; Cajimat M; Chua PK; Shih C
J Virol; 2003 Dec; 77(24):12950-60. PubMed ID: 14645551
[TBL] [Abstract][Full Text] [Related]
10. Influence of the basal core promoter and precore mutation on replication of hepatitis B virus and antiviral susceptibility of different genotypes.
Cui XJ; Cho YK; Song BC
J Med Virol; 2015 Apr; 87(4):601-8. PubMed ID: 25612255
[TBL] [Abstract][Full Text] [Related]
11. Region-Specific Hepatitis B Virus Genome Exposure from Nucleocapsid Modulated by Capsid Linker Sequence and Inhibitor: Implications for Uncoating.
Xi J; Cui X; Liu K; Liu H; Wang J; Hu J
J Virol; 2022 Apr; 96(8):e0039922. PubMed ID: 35389266
[TBL] [Abstract][Full Text] [Related]
12. Virion Secretion of Hepatitis B Virus Naturally Occurring Core Antigen Variants.
Shih C; Wu SY; Chou SF; Yuan TT
Cells; 2020 Dec; 10(1):. PubMed ID: 33396864
[TBL] [Abstract][Full Text] [Related]
13. Hepatitis B virus capsid assembly is enhanced by naturally occurring mutation F97L.
Ceres P; Stray SJ; Zlotnick A
J Virol; 2004 Sep; 78(17):9538-43. PubMed ID: 15308745
[TBL] [Abstract][Full Text] [Related]
14. In vitro resistance to interferon of hepatitis B virus with precore mutation.
Wang Y; Wei L; Jiang D; Cong X; Fei R; Xiao J; Wang Y
World J Gastroenterol; 2005 Feb; 11(5):649-55. PubMed ID: 15655815
[TBL] [Abstract][Full Text] [Related]
15. Stable HepG2- and Huh7-based human hepatoma cell lines for efficient regulated expression of infectious hepatitis B virus.
Sun D; Nassal M
J Hepatol; 2006 Nov; 45(5):636-45. PubMed ID: 16935386
[TBL] [Abstract][Full Text] [Related]
16. Hepatitis B virus pre-S/S variants in liver diseases.
Chen BF
World J Gastroenterol; 2018 Apr; 24(14):1507-1520. PubMed ID: 29662289
[TBL] [Abstract][Full Text] [Related]
17. Hepatitis B virus (HBV) virion and covalently closed circular DNA formation in primary tupaia hepatocytes and human hepatoma cell lines upon HBV genome transduction with replication-defective adenovirus vectors.
Ren S; Nassal M
J Virol; 2001 Feb; 75(3):1104-16. PubMed ID: 11152483
[TBL] [Abstract][Full Text] [Related]
18. Pregenomic RNA Launch Hepatitis B Virus Replication System Facilitates the Mechanistic Study of Antiviral Agents and Drug-Resistant Variants on Covalently Closed Circular DNA Synthesis.
Zhao Q; Chang J; Rijnbrand R; Lam AM; Sofia MJ; Cuconati A; Guo JT
J Virol; 2022 Dec; 96(24):e0115022. PubMed ID: 36448800
[TBL] [Abstract][Full Text] [Related]
19. Conserved Lysine Residues of Hepatitis B Virus Core Protein Are Not Required for Covalently Closed Circular DNA Formation.
Hong X; Hu J
J Virol; 2022 Aug; 96(15):e0071822. PubMed ID: 35867543
[TBL] [Abstract][Full Text] [Related]
20. Core I97L mutation in conjunction with P79Q is associated with persistent low HBV DNA and HBs antigen clearance in patients with chronic hepatitis B.
Honda T; Ishigami M; Ishizu Y; Kuzuya T; Hayashi K; Ishikawa T; Murakami Y; Iwadate M; Umeyama H; Toyoda H; Kumada T; Katano Y; Goto H; Hirooka Y
Clin Microbiol Infect; 2017 Jun; 23(6):407.e1-407.e7. PubMed ID: 27998820
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
